132 related articles for article (PubMed ID: 3366173)
1. Demonstration of a distinct class of high-affinity binding sites for [3H]norharman [( 3H]beta-carboline) in the rat brain.
Pawlik M; Rommelspacher H
Eur J Pharmacol; 1988 Mar; 147(2):163-71. PubMed ID: 3366173
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
May T; Greube A; Strauss S; Heineke D; Lehmann J; Rommelspacher H
Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):308-17. PubMed ID: 8208308
[TBL] [Abstract][Full Text] [Related]
3. Quantitative autoradiography of [3H]norharman [( 3H]beta-carboline) binding sites in the rat brain.
Pawlik M; Kaulen P; Baumgarten HG; Rommelspacher H
J Chem Neuroanat; 1990; 3(1):19-24. PubMed ID: 2156525
[TBL] [Abstract][Full Text] [Related]
4. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats.
Rommelspacher H; May T; Salewski B
Eur J Pharmacol; 1994 Jan; 252(1):51-9. PubMed ID: 8149995
[TBL] [Abstract][Full Text] [Related]
5. [3H]norharman ([3H]beta-carboline) binds reversibly and with high affinity to a specific binding site in rat liver.
Greube A; Rommelspacher H
Neurochem Res; 1993 Sep; 18(9):1029-31. PubMed ID: 8232719
[TBL] [Abstract][Full Text] [Related]
6. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
7. The high-affinity binding of [3H]norharman ([3H]beta-carboline) to the ethanol-inducible cytochrome P450 2E1 in rat liver.
Stawowy P; Bonnet R; Rommelspacher H
Biochem Pharmacol; 1999 Mar; 57(5):511-20. PubMed ID: 9952314
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-phenylpyridinium (MPP+) binds with high affinity to a beta-carboline binding site located on monoamine oxidase type A in rat brain.
May T
Neurosci Lett; 1993 Nov; 162(1-2):55-8. PubMed ID: 8121637
[TBL] [Abstract][Full Text] [Related]
10. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee.
Herraiz T; Chaparro C
Life Sci; 2006 Jan; 78(8):795-802. PubMed ID: 16139309
[TBL] [Abstract][Full Text] [Related]
11. Kindling of seizures with norharman, a beta-carboline ligand of benzodiazepine receptors.
Morin AM; Watson AL; Wasterlain CG
Eur J Pharmacol; 1983 Mar; 88(1):131-4. PubMed ID: 6303806
[No Abstract] [Full Text] [Related]
12. [3H]harman binding experiments. I: A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat.
May T; Rommelspacher H; Pawlik M
J Neurochem; 1991 Feb; 56(2):490-9. PubMed ID: 1988552
[TBL] [Abstract][Full Text] [Related]
13. Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 1. Norharman and 4-phenylimidazole binding to the enzyme as inhibitors and heme ligands.
Sono M; Cady SG
Biochemistry; 1989 Jun; 28(13):5392-9. PubMed ID: 2789076
[TBL] [Abstract][Full Text] [Related]
14. Isolation and identification of two [(3)H]norharman- ([(3)H]beta-carboline)-binding proteins from rat liver.
Greube A; Rommelspacher H
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 784(1):155-68. PubMed ID: 12504194
[TBL] [Abstract][Full Text] [Related]
15. [3H]harman binding experiments. II: Regional and subcellular distribution of specific [3H]harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat.
May T; Pawlik M; Rommelspacher H
J Neurochem; 1991 Feb; 56(2):500-8. PubMed ID: 1988553
[TBL] [Abstract][Full Text] [Related]
16. beta-Carboline binding to deoxycholate solubilized benzodiazepine receptors from calf cerebral cortex.
Sherman-Gold R; Dudai Y
Neurosci Lett; 1981 Nov; 26(3):325-8. PubMed ID: 6895661
[TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding.
Rommelspacher H; Nanz C; Borbe HO; Fehske KJ; Müller WE; Wollert U
Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):97-100. PubMed ID: 6255348
[TBL] [Abstract][Full Text] [Related]
18. Oxidative metabolism of the bioactive and naturally occurring beta-carboline alkaloids, norharman and harman, by human cytochrome P450 enzymes.
Herraiz T; Guillén H; Arán VJ
Chem Res Toxicol; 2008 Nov; 21(11):2172-80. PubMed ID: 19238614
[TBL] [Abstract][Full Text] [Related]
19. Activation by beta-carbolines of G-proteins in HL-60 membranes and the bovine retinal G-protein transducin in a receptor-independent manner.
Klinker JF; Seifert R; Damm H; Rommelspacher H
Biochem Pharmacol; 1997 Jun; 53(11):1621-6. PubMed ID: 9264314
[TBL] [Abstract][Full Text] [Related]
20. Norharman (beta-carboline) as a potent inhibitory ligand for steroidogenic cytochromes P450 (CYP11 and CYP17).
Kühn-Velten WN
Eur J Pharmacol; 1993 Nov; 250(1):R1-3. PubMed ID: 8119304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
